NU SKIN ENTERPRISES INC - A (NUS)
US67018T1051 - Common Stock
Taking everything into account, NUS scores 4 out of 10 in our fundamental rating. NUS was compared to 37 industry peers in the Personal Care Products industry. NUS has an average financial health and profitability rating. NUS is cheap, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year NUS was profitable.
In the past year NUS had a positive cash flow from operations.
Each year in the past 5 years NUS has been profitable.
NUS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
NUS's Return On Assets of 0.48% is in line compared to the rest of the industry. NUS outperforms 43.24% of its industry peers.
NUS's Return On Equity of 1.04% is in line compared to the rest of the industry. NUS outperforms 48.65% of its industry peers.
With a Return On Invested Capital value of 3.64%, NUS perfoms like the industry average, outperforming 48.65% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for NUS is significantly below the industry average of 14.69%.
The 3 year average ROIC (9.55%) for NUS is well above the current ROIC(3.64%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.48% | ||
| ROE | 1.04% | ||
| ROIC | 3.64% |
ROA(3y)4.65%
ROA(5y)6.71%
ROE(3y)9.62%
ROE(5y)14.02%
ROIC(3y)9.55%
ROIC(5y)11.6%
1.3 Margins
NUS has a Profit Margin of 0.44%. This is comparable to the rest of the industry: NUS outperforms 43.24% of its industry peers.
In the last couple of years the Profit Margin of NUS has declined.
With a Operating Margin value of 3.46%, NUS perfoms like the industry average, outperforming 51.35% of the companies in the same industry.
NUS's Operating Margin has declined in the last couple of years.
The Gross Margin of NUS (68.93%) is better than 62.16% of its industry peers.
NUS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.46% | ||
| PM (TTM) | 0.44% | ||
| GM | 68.93% |
OM growth 3Y-29.77%
OM growth 5Y-21.55%
PM growth 3Y-61.1%
PM growth 5Y-37.43%
GM growth 3Y-2.56%
GM growth 5Y-2.02%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NUS is creating some value.
NUS has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, NUS has less shares outstanding
NUS has a worse debt/assets ratio than last year.
2.2 Solvency
NUS has an Altman-Z score of 3.29. This indicates that NUS is financially healthy and has little risk of bankruptcy at the moment.
NUS's Altman-Z score of 3.29 is fine compared to the rest of the industry. NUS outperforms 64.86% of its industry peers.
NUS has a debt to FCF ratio of 8.36. This is a slightly negative value and a sign of low solvency as NUS would need 8.36 years to pay back of all of its debts.
NUS has a Debt to FCF ratio (8.36) which is comparable to the rest of the industry.
NUS has a Debt/Equity ratio of 0.58. This is a neutral value indicating NUS is somewhat dependend on debt financing.
NUS has a Debt to Equity ratio of 0.58. This is in the lower half of the industry: NUS underperforms 62.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | 8.36 | ||
| Altman-Z | 3.29 |
ROIC/WACC0.41
WACC8.91%
2.3 Liquidity
A Current Ratio of 2.13 indicates that NUS has no problem at all paying its short term obligations.
NUS has a Current ratio (2.13) which is comparable to the rest of the industry.
A Quick Ratio of 1.28 indicates that NUS should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.28, NUS perfoms like the industry average, outperforming 51.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.13 | ||
| Quick Ratio | 1.28 |
3. Growth
3.1 Past
NUS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.33%.
The earnings per share for NUS have been decreasing by -13.77% on average. This is quite bad
Looking at the last year, NUS shows a very negative growth in Revenue. The Revenue has decreased by -11.52% in the last year.
Measured over the past years, NUS shows a decrease in Revenue. The Revenue has been decreasing by -5.97% on average per year.
EPS 1Y (TTM)-36.33%
EPS 3Y-20.41%
EPS 5Y-13.77%
EPS growth Q2Q-58.43%
Revenue 1Y (TTM)-11.52%
Revenue growth 3Y-8.64%
Revenue growth 5Y-5.97%
Revenue growth Q2Q-6.44%
3.2 Future
The Earnings Per Share is expected to decrease by -7.65% on average over the next years.
NUS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.25% yearly.
EPS Next Y-37.66%
EPS Next 2Y-7.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-7.29%
Revenue Next 2Y-2.25%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 7.07, which indicates a rather cheap valuation of NUS.
Compared to the rest of the industry, the Price/Earnings ratio of NUS indicates a rather cheap valuation: NUS is cheaper than 94.59% of the companies listed in the same industry.
NUS is valuated cheaply when we compare the Price/Earnings ratio to 24.76, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 11.34 indicates a reasonable valuation of NUS.
89.19% of the companies in the same industry are more expensive than NUS, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of NUS to the average of the S&P500 Index (21.26), we can say NUS is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.07 | ||
| Fwd PE | 11.34 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NUS is valued cheaper than 91.89% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, NUS is valued cheaply inside the industry as 83.78% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.69 | ||
| EV/EBITDA | 6.12 |
4.3 Compensation for Growth
A cheap valuation may be justified as NUS's earnings are expected to decrease with -7.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.65%
EPS Next 3YN/A
5. Dividend
5.1 Amount
NUS has a Yearly Dividend Yield of 1.96%. Purely for dividend investing, there may be better candidates out there.
The stock price of NUS dropped by -25.14% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 5.14, NUS pays a bit more dividend than its industry peers.
NUS's Dividend Yield is comparable with the S&P500 average which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.96% |
5.2 History
The dividend of NUS has a limited annual growth rate of 1.01%.
NUS has paid a dividend for at least 10 years, which is a reliable track record.
NUS has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)1.01%
Div Incr Years19
Div Non Decr Years19
5.3 Sustainability
904.47% of the earnings are spent on dividend by NUS. This is not a sustainable payout ratio.
The Dividend Rate of NUS has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP904.47%
EPS Next 2Y-7.65%
EPS Next 3YN/A
NU SKIN ENTERPRISES INC - A
NYSE:NUS (4/19/2024, 7:07:18 PM)
After market: 13.01 0 (0%)13.01
+0.31 (+2.44%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap642.95M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.96% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.07 | ||
| Fwd PE | 11.34 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.48% | ||
| ROE | 1.04% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 3.46% | ||
| PM (TTM) | 0.44% | ||
| GM | 68.93% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.13 | ||
| Quick Ratio | 1.28 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-36.33%
EPS 3Y-20.41%
EPS 5Y
EPS growth Q2Q
EPS Next Y-37.66%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-11.52%
Revenue growth 3Y-8.64%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y